HSCA Comments on FDA Bulk Substance Guidance
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Food and Drug Administration (FDA) draft guidance on the use of bulk substances under Section 503B of the Federal Food, Drug, and Cosmetic Act. HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of America’s 7,000+ hospitals.
Comments of the Healthcare Supply Chain Association (HSCA) on Supported Lifetimes and Legacy Medical Devices
May 31, 2018
Advances in information technology and medical devices, and increasing...
HSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
September 19, 2018
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...